Polymorphism creates a development problem before it becomes a formulation problem. A natural product candidate may appear to have an acceptable solid form while its accessible crystal landscape remains incompletely sampled, its energetic ordering uncertain, or its crystallization behavior sensitive to solvent, temperature, and molecular conformation. This article develops a proposed decision framework for assessing polymorph risk before formulation choices become difficult to reverse. The analy
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: